Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies

Journal of Zhejiang University: Science B

Volumn 16, Issue 1, 2015, Pages 78-86

  Peng, Hui yong ^a   Man, Chang feng ^a   Xu, Juan ^a   Fan, Yu ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

All cause mortality; Cardiovascular mortality; Coronary heart disease; Homocysteine; Meta analysis

Indexed keywords

HOMOCYSTEINE;

ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMPARATIVE STUDY; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; ADULT; AGED; BLOOD; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CORONARY DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDIES AS TOPIC; ODDS RATIO; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84920773897     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1400183     Document Type: Article

References (31)

1. Bautista, L.E., Arenas, I.A., Penuela, A., et al., 2002. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J. Clin. Epidemiol., 55(9):882–887. [doi:10.1016/S0895-4356(02)00434-1]
2. Begg, C.B., Mazumdar, M., 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics, 50(4):1088–1101. [doi:10.2307/2533446]
3. Blacher, J., Benetos, A., Kirzin, J.M., et al., 2002. Relation of plasma total homocysteine to cardiovascular mortality in a French population. Am. J. Cardiol., 90(6):591–595. [doi:10.1016/S0002-9149(02)02561-4]
4. Bostom, A.G., Silbershatz, H., Rosenberg, I.H., et al., 1999. Nonfasting plasma total homocysteine levels and allcause and cardiovascular disease mortality in elderly Framingham men and women. Arch. Intern. Med., 159(10):1077–1080. [doi:10.1001/archinte.159.10.1077]
5. Celermajer, D.S., Sorensen, K., Ryalls, M., et al., 1993. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J. Am. Coll. Cardiol., 22(3):854–858. [doi:10.1016/0735-1097(93)90203-D]
6. Colon Lopez, V., Haan, M.N., Aiello, A.E., et al., 2008. Fasting total homocysteine (THCY) concentration and mortality in older Mexican Americans. J. Nutr. Health. Aging, 12(10):685–689.
7. Cui, R., Moriyama, Y., Koike, K.A., et al., 2008. Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study. Atherosclerosis, 198(2):412–418. [doi:10.1016/j.atherosclerosis.2007.09.029]
8. Dangour, A.D., Breeze, E., Clarke, R., et al., 2008. Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom. J. Nutr., 138(6):1121–1128.
9. de Bree, A., Verschuren, W.M., Blom, H.J., et al., 2003. Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study. Atherosclerosis, 166(2):369–377. [doi:10.1016/S0021-9150(02)00373-8]
10. Dionisio, N., Jardin, I., Salido, G.M., et al., 2010. Homocysteine, intracellular signaling and thrombotic disorders. Curr. Med. Chem., 17(27):3109–3119. [doi:10.2174/092986710791959783]
11. Egger, M., Davey Smith, G., Schneider, M., et al., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109):629–634. [doi:10.1136/bmj.315.7109.629]
12. Gonzalez, S., Huerta, J.M., Fernandez, S., et al., 2007. Homocysteine increases the risk of mortality in elderly individuals. Br. J. Nutr., 97(6):1138–1143. [doi:10.1017/S0007114507691958]
13. Higgins, J.P., Thompson, S.G., Deeks, J.J., et al., 2003. Measuring inconsistency in meta-analyses. BMJ, 327(7414):557–560. [doi:10.1136/bmj.327.7414.557]
14. Ho, R.C., Cheung, M.W., Fu, E., et al., 2011. Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and metaregression. Am. J. Geriatr. Psychiatry, 19(7):607–617. [doi:10.1097/JGP.0b013e3181f17eed]
15. Hoogeveen, E.K., Kostense, P.J., Jakobs, C., et al., 2000. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn study. Circulation, 101(13):1506–1511. [doi:10.1161/01.CIR.101.13.1506]
16. Kark, J.D., Selhub, J., Adler, B., et al., 1999. Nonfasting plasma total homocysteine level and mortality in middleaged and elderly men and women in Jerusalem. Ann. Intern. Med., 131(5):321–330. [doi:10.7326/0003-4819-131-5-199909070-00002]
17. Naess, H., Nyland, H., Idicula, T., et al., 2013. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients. J. Stroke. Cerebrovasc. Dis., 22(8):e435–e440. [doi:10.1016/j.jstrokecerebrovasdis.2013.04.031]
18. Nygård, O., Vollset, S.E., Refsum, H., et al., 1995. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA, 274(19):1526–1533. [doi:10.1001/jama.274.19.1526]
19. Nygård, O., Nordrehaug, J.E., Refsum, H., et al., 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med., 337(4):230–236. [doi:10.1056/NEJM199707243370403]
20. Rossi, G.P., Maiolino, G., Seccia, T.M., et al., 2006. Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. J. Hypertens., 24(5):851–859. [doi:10.1097/01.hjh.0000222754.75196.5c]
21. Selhub, J., 2006. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J. Nutr., 136(6S):1726S–1730S.
22. Selhub, J., Jacques, P.F., Wilson, P.W., et al., 1993. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA, 270(22):2693–2698. [doi:10.1001/jama.1993.03510220049033]
23. Stehouwer, C.D., Weijenberg, M.P., van den Berg, M., et al., 1998. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler. Thromb. Vasc. Biol., 18(12):1895–1901. [doi:10.1161/01.ATV.18.12.1895]
24. Stroup, D.F., Berlin, J.A., Morton, S.C., et al., 2000. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, 283(15): 2008–2012. [doi:10.1001/jama.283.15.2008]
25. Swart, K.M., van Schoor, N.M., Blom, H.J., et al., 2012. Homocysteine and the risk of nursing home admission and mortality in older persons. Eur. J. Clin. Nutr., 66(2): 188–195. [doi:10.1038/ejcn.2011.186]
26. Vollset, S.E., Refsum, H., Tverdal, A., et al., 2001. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the hordaland homocysteine study. Am. J. Clin. Nutr., 74(1):130–136.
27. Waśkiewicz, A., Sygnowska, E., Broda, G., 2012. Homocysteine concentration and the risk of death in the adult polish population. Kardiol. Pol., 70(9):897–902.
28. Wells, G., Shea, B.O., Connell, D., et al., 2013. The Newcastle-Ottawa scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [Accessed on Oct. 6, 2013].
29. Wong, Y.Y., Almeida, O.P., Mccaul, K.A., et al., 2012. Homocysteine, frailty, and all-cause mortality in older men: the health in men study. J. Gerontol. A Biol. Sci. Med. Sci., 68(5):590–598. [doi:10.1093/gerona/gls211]
30. Yang, J., Hu, X., Zhang, Q., et al., 2012. Homocysteine level and risk of fracture: a meta-analysis and systematic review. Bone, 51(3):376–382. [doi:10.1016/j.bone.2012.05.024]
31. Zylberstein, D.E., Bengtsson, C., Bjorkelund, C., et al., 2004. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg. Circulation, 109(5):601–606. [doi:10.1161/01.CIR.0000112581.96154.EA]